DRREDDY — Dr. Reddy's Laboratories Share News
0.000.00%
Last trade - 00:00- IN₹1.02tn
- IN₹1.01tn
- IN₹337.00bn
India approves Novo Nordisk's obesity drug Wegovy for fatty liver disease
India's Dr Reddy's logs worst week in 3 years as semaglutide disruption fuels growth concerns
India's Dr Reddy's posts worst week in 3 years as semaglutide setback stokes growth fears (updated)
India's Dr Reddy's on course for second straight day of losses on semaglutide shipping disruption
Dr Reddy's extends slide as semaglutide supply snag raises earnings risks
India's Torrent Pharma recalls select semaglutide pens after Dr. Reddy's notice
Brief: Dr Reddy's Exec Says Short Of Earlier Predicted Target, We Now Think We Can Sell 6 To 7 Million In Fiscal 2027
India's Dr Reddy's falls on semaglutide supply delay due to API issue
Brief: Onesource Specialty Pharma Says Delay In Dr Reddy's Supplies Does Not Materially Impact Co's Operations
India's Dr Reddy's says semaglutide shipping disruption to last until at least late October (updated)
Corrected: BUZZ-India's Dr Reddy's falls on semaglutide supply delay due to API issue
Corrected: Dr Reddy's delays semaglutide commercial supply due to active ingredient issue
Brief: Dr Reddy's Says Certain Semaglutide Batches Found Out Of Specification Due To API Issue
India's Dr Reddy’s falls as brokerages flag weak US growth, regulatory risks
India Stocks: Indian shares subdued after recent gains on monsoon worries
India's Dr Reddy's rises as analysts project no material impact from US FDA observations
India's Dr Reddy's up as Nomura hikes PT on positive view on earnings, valuations
Focus: US progesterone supplies tighten as menopause treatment demand grows
Factbox: Global drugmakers invest billions to boost US presence